Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guselkumab and DermaToolbox in Psoriasis
NCT04394936Terminated
- Sponsor
- Centre for Human Drug Research
- Start
- Sep 2020
- Primary completion
- Feb 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Randomised, double-blind trial of guselkumab in plaque psoriasis (3 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Psoriasis Area and Severity Index, Physicians Global Assessment and 12 more. Started Sep 2020; status: terminated.
02
Drugs
guselkumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04394936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394936.